Cessation of bleeding after a 30 minutes 30 minutes [clinicaltrials_resource:0a4ce81add516f6ebb21063f3384bef0]
The primary endpoint is a cessation of bleeding after a 30 minute period. Evaluation of bleeding will be performed by an independent evaluator, who will determine if the bleeding has stopped.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Cessation of bleeding after a 30 minutes 30 minutes [clinicaltrials_resource:0a4ce81add516f6ebb21063f3384bef0]
The primary endpoint is a cessation of bleeding after a 30 minute period. Evaluation of bleeding will be performed by an independent evaluator, who will determine if the bleeding has stopped.
Bio2RDF identifier
0a4ce81add516f6ebb21063f3384bef0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0a4ce81add516f6ebb21063f3384bef0
measure [clinicaltrials_vocabulary:measure]
Cessation of bleeding after a 30 minutes
time frame [clinicaltrials_vocabulary:time-frame]
30 minutes
description
The primary endpoint is a cess ...... e if the bleeding has stopped.
identifier
clinicaltrials_resource:0a4ce81add516f6ebb21063f3384bef0
title
Cessation of bleeding after a 30 minutes 30 minutes
@en
type
label
Cessation of bleeding after a ...... ce81add516f6ebb21063f3384bef0]
@en